Abcellera Biologics Inc (ABCL) Stock Price, Quote & News

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research coll...

Industry: Biotechnology

Sector: Healthcare

Phone: 604 559 9005

Website: www.abcellera.com

Address:

150 West 4th Ave, Vancouver, Canada

Stocktradesmoon Oct. 22 at 11:28 AM

$ABCL BREAKING NEWS ALERT ‼️ HEAVILY SHORTED STOCKS ARE CONTINUING TO RISE AND IS THE MAIN THEME OF THE MARKET 👀😉

0 · Reply

Stocktradesmoon Oct. 22 at 10:46 AM

$ABCL $ABCL is going to skyrocket 🚀 There is a big probability to nearly double the price at the end of this year.

0 · Reply

Stocktradesmoon Oct. 22 at 10:43 AM

$ABCL 🚩 $ABCL setting up a classic bull flag 📈 Pole: $3.66 → $6.50 📉 Flag: Consolidation $5.50–$6.50 🎯 Breakout target: $9.30+ ✅ Holding 50/100/200 MA 🔥 Volume fading = textbook setup 👀 Watching for $6.50 breakout confirmation #ABCL #biotech #stocks #bullflag #TA

0 · Reply

Stocktradesmoon Oct. 22 at 1:31 AM

$ABCL Understand this: Unusual strength → track it. Random behavior → ignore it. Tight consolidation after strength → focus on it. Keep it simple. Keep it repeatable.

0 · Reply

DeMampCamp Oct. 21 at 7:32 PM

$ABCL Is there a company out there that delivers less PRs than ABCL? Hard to believe!

1 · Reply

Ed_Ng Oct. 21 at 6:19 PM

$ABCL afternoon dipper. Typical pump and dump penny stock. Good luck, gamblers!

0 · Reply

Ed_Ng Oct. 21 at 6:18 PM

$ABCL pos

0 · Reply

MikeyCook Oct. 21 at 5:06 PM

$ABCL gap filled and bounced. Back up we go!

0 · Reply

Plutten1973 Oct. 21 at 4:57 PM

$ABCL 5.53 bottom!

0 · Reply

Stocktradesmoon Oct. 21 at 2:48 PM

$ABCL The typical morning dip for an afternoon rip.....

0 · Reply

AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

Oct 6, 2025, 7:35 AM EDT - 16 days ago

AbCellera Biologics: Entering Growth Phase After A Pause

Sep 29, 2025, 4:05 PM EDT - 22 days ago

AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025

Sep 10, 2025, 9:07 AM EDT - 6 weeks ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Aug 27, 2025, 9:00 AM EDT - 2 months ago

AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575

Aug 12, 2025, 4:05 PM EDT - 2 months ago

AbCellera to Participate at Upcoming Investor Conferences in September

Aug 7, 2025, 7:48 PM EDT - 2 months ago

AbCellera Biologics Inc. (ABCL) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:05 PM EDT - 2 months ago

AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms

Jul 7, 2025, 4:05 PM EDT - 3 months ago

AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025

May 30, 2025, 1:00 PM EDT - 5 months ago

AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575

May 14, 2025, 5:00 PM EDT - 5 months ago

AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause

May 12, 2025, 3:30 PM EDT - 5 months ago

AbCellera's Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit

May 9, 2025, 7:30 PM EDT - 5 months ago

AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

May 8, 2025, 10:33 PM EDT - 5 months ago

AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:05 PM EDT - 5 months ago

AbCellera Reports Q1 2025 Business Results

Apr 29, 2025, 3:00 PM EDT - 6 months ago

AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025

Apr 8, 2025, 4:05 PM EDT - 7 months ago

AbCellera to Participate at Upcoming Investor Conferences in May and June

Apr 3, 2025, 4:05 PM EDT - 7 months ago

AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025

Mar 25, 2025, 4:30 PM EDT - 7 months ago

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

Feb 27, 2025, 11:26 PM EST - 8 months ago

AbCellera Biologics Inc. (ABCL) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:05 PM EST - 8 months ago

AbCellera Reports Full Year 2024 Business Results

Feb 11, 2025, 4:05 PM EST - 9 months ago

AbCellera to Participate at Upcoming Investor Conferences in March

Jan 21, 2025, 4:05 PM EST - 9 months ago

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025

Jan 13, 2025, 9:00 AM EST - 10 months ago

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

Dec 23, 2024, 4:39 PM EST - 10 months ago

AbCellera Biologics: Still A Concept Stock

Nov 21, 2024, 4:05 PM EST - 11 months ago

AbCellera to Present at Upcoming Investor Conferences in December and January

Nov 7, 2024, 10:05 AM EST - 1 year ago

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024

Nov 4, 2024, 7:22 PM EST - 1 year ago

AbCellera Biologics Inc. (ABCL) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results

Oct 22, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in November 2024

Oct 14, 2024, 12:04 PM EDT - 1 year ago

AbCellera: A Platform To Pipeline Transition

Oct 4, 2024, 9:00 AM EDT - 1 year ago

AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024

Sep 26, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024

Aug 29, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in September

Aug 23, 2024, 4:43 AM EDT - 1 year ago

AbCellera: A Waiting Game With High Uncertainty

Aug 20, 2024, 9:45 AM EDT - 1 year ago

This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

GLOB AVDX LRN PGRU

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results

Jul 31, 2024, 9:00 AM EDT - 1 year ago

AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines

Jun 25, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024

May 28, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024

May 7, 2024, 11:00 PM EDT - 1 year ago

AbCellera Biologics Inc. (ABCL) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2024 Business Results

May 1, 2024, 9:00 AM EDT - 1 year ago

AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies

Apr 8, 2024, 12:05 PM EDT - 1 year ago

AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024

Apr 3, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024

Mar 19, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024

Mar 11, 2024, 9:00 AM EDT - 1 year ago

AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions

BIIB

Mar 5, 2024, 4:30 PM EST - 1 year ago

AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024

Feb 23, 2024, 4:30 PM EST - 1 year ago

AbCellera Announces Resignation of Board Member

Feb 22, 2024, 8:15 PM EST - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in March

Stocktradesmoon Oct. 22 at 11:28 AM

$ABCL BREAKING NEWS ALERT ‼️ HEAVILY SHORTED STOCKS ARE CONTINUING TO RISE AND IS THE MAIN THEME OF THE MARKET 👀😉

0 · Reply

Stocktradesmoon Oct. 22 at 10:46 AM

$ABCL $ABCL is going to skyrocket 🚀 There is a big probability to nearly double the price at the end of this year.

0 · Reply

Stocktradesmoon Oct. 22 at 10:43 AM

0 · Reply

Stocktradesmoon Oct. 22 at 1:31 AM

$ABCL Understand this: Unusual strength → track it. Random behavior → ignore it. Tight consolidation after strength → focus on it. Keep it simple. Keep it repeatable.

0 · Reply

DeMampCamp Oct. 21 at 7:32 PM

$ABCL Is there a company out there that delivers less PRs than ABCL? Hard to believe!

1 · Reply

Ed_Ng Oct. 21 at 6:19 PM

$ABCL afternoon dipper. Typical pump and dump penny stock. Good luck, gamblers!

0 · Reply

Ed_Ng Oct. 21 at 6:18 PM

$ABCL pos

0 · Reply

MikeyCook Oct. 21 at 5:06 PM

$ABCL gap filled and bounced. Back up we go!

0 · Reply

Plutten1973 Oct. 21 at 4:57 PM

$ABCL 5.53 bottom!

0 · Reply

Stocktradesmoon Oct. 21 at 2:48 PM

$ABCL The typical morning dip for an afternoon rip.....

0 · Reply

Stocktradesmoon Oct. 21 at 8:25 AM

$ABCL $ABCL still holding its bull flag

0 · Reply

Stocktradesmoon Oct. 21 at 3:13 AM

$ABCL The bios are the new uranium 👀😉🚀🚀🚀🚀🚀🚀🚀🚀 PLEASE DO NOT MISS THE HUGE MOVE THATS COMING!!!! DOUBLE DIGITS VERY SOON!!!! All signs point to a huge breakout move coming very soon!!! Stay focused, buy now, hold, and get ready for the huge POWER MOVE!!!

0 · Reply

Stocktradesmoon Oct. 20 at 10:30 PM

$ABCL The two most impactful AI themes still have yet to completely take off... the best is yet to come. If you feel FOMO because you missed quantum and nuclear, don’t. AI in healthcare-genomics and robotics are coming.

1 · Reply

Stocktradesmoon Oct. 20 at 8:57 PM

$ABCL $ABCL it’s coming! 👀😉🚀🚀🚀🚀 SHORTS DAYS ARE NUMBERED!!! With Biotechs on the move and $LABU not showing signs of stopping, I think these are the ones moving the best at the moment. This one has huge momentum and linearity, looking for a breakout. The Setup - First leg of a fresh new trend, 70% move from the low - 8>20>50 EMAs - First valid consolidation built and mature at the 8/20 EMA layer - My CML indicator flashing GREEN - Now needs 1-3 days to tighten up and break out...

0 · Reply

WillC56 Oct. 20 at 8:51 PM

$ABCL weekly and monthly looking 👌

0 · Reply

RocroBio Oct. 20 at 7:51 PM

$ABCL $CRBU $CRSP $EDIT

0 · Reply

Ed_Ng Oct. 20 at 7:23 PM

$ABCL yeah. Pump to 6.5$ and dump to 2$. Really shock.

1 · Reply

Stocktradesmoon Oct. 20 at 6:04 PM

$ABCL In a few weeks, $ABCL is going to shock the world. 👀😉

0 · Reply

Stocktradesmoon Oct. 20 at 3:01 PM

$ABCL The beauty of $ABCL model — they’re not betting on one drug. They’re building a platform that earns from many. Low burn, strong cash position, and 100+ partnered programs = asymmetric setup once a few hit late-stage trials. Patience will pay here.

0 · Reply

LiquidThetaLEAPS Oct. 20 at 11:15 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $ABCL Current Share Price: $5.59 Contracts: $ABCL January 15, 2027 $7 Calls Scale in: $1.87- $2.29 Scale out: $2.91-$3.74 Can Easily Capture: 60% ROI Blended DTE: 453 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

Stocktradesmoon Oct. 20 at 3:27 AM

$ABCL $ABCL grinding up this channel is how we get over this vwap’s

0 · Reply

Stocktradesmoon Oct. 20 at 2:21 AM

$ABCL I have on good word look for a huge push this week on $ABCL POWER MOVE INCOMING!!! Looking for a move above $7.50+

0 · Reply

Market Cap	1.75B
Revenue (ttm)	28.83M
Net Income (ttm)	-162.86M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-564.90%
Debt to Equity Ratio	0.00

Volume	4,260,300
Avg Vol	5,163,060
Day's Range	N/A - N/A
Shares Out	298.83M
Stochastic %K	26%
Beta	0.69
Analysts	Strong Sell
Price Target	$9.29